EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia

EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia

EZH2 is overexpressed in poor-prognostic chronic lymphocytic leukaemia (CLL) cases, acting as an oncogene; however, thus far, the EZH2 target genes in CLL have not been disclosed. In this study, using ChIP-sequencing, we identified EZH2 and H3K27me3 target genes in two prognostic subgroups of CLL wi...

Full description

Bibliographic Details
Main Authors: Subazini Thankaswamy Kosalai, Mohammad Hamdy Abdelrazak Morsy, Nikos Papakonstantinou, Larry Mansouri, Niki Stavroyianni, Chandrasekhar Kanduri, Kostas Stamatopoulos, Richard Rosenquist, Meena Kanduri
Format: Article
Language:English
Published: Taylor & Francis Group 2019-11-01
Series:Epigenetics
Subjects:
chronic lymphocytic leukemia
ezh2
chip sequencing
pi3k pathway
igfr1
Online Access:http://dx.doi.org/10.1080/15592294.2019.1633867

Internet

http://dx.doi.org/10.1080/15592294.2019.1633867

Similar Items